Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Convelo Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Convelo Therapeutics

Convelo Therapeutics

Series A

Convelo Therapeutics: Innovating myelin regeneration treatments via stem cell stimulation.

HQ
Cleveland, OH, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Convelo Therapeutics, founded with the mission to revolutionize treatments for neurological disorders, focuses on developing medicines that regenerate myelin around nerve cells. Their core vision is to restore neurological function by leveraging an innovative platform that identifies novel candidate treatments. These treatments aim to directly stimulate stem cells in the central nervous system to form new myelin, addressing conditions like Multiple Sclerosis.

Notable figures affiliated with Convelo Therapeutics include leading scientists and executives in the field of neurology and regenerative medicine. The company has garnered significant attention and investment due to its groundbreaking approach and potential impact on treating demyelinating diseases. Convelo's key achievements include the development of a proprietary platform for remyelination, positioning them as a pioneering force in neurological therapeutics.

Convelo Therapeutics - Similar Companies

Convalesce logo

Convalesce

convalesce.co

Novoron Bioscience logo

Novoron Bioscience

novoron.com

Bolden Therapeutics logo

Bolden Therapeutics

Myrobalan Therapeutics logo

Myrobalan Therapeutics

myrotx.com

Pipeline Therapeutics logo

Pipeline Therapeutics

Celvive logo

Celvive

Convoy Therapeutics logo

Convoy Therapeutics

Autobahn Therapeutics logo

Autobahn Therapeutics

autobahntx.com

NeuExcell Therapeutics logo

NeuExcell Therapeutics

neuexcell.com

Regennova logo

Regennova

regennova.com

Neurona Therapeutics logo

Neurona Therapeutics

ReNetX Bio logo

ReNetX Bio

renetx.com

Stemson Therapeutics logo

Stemson Therapeutics

stemsontx.com

Convergent Therapeutics logo

Convergent Therapeutics

convergentrx.com

Cell Reprogramming & Therapeutics logo

Cell Reprogramming & Therapeutics

Convelo Therapeutics - Quick Facts

Who are Convelo Therapeutics' competitors?

Companies similar to Convelo Therapeutics include Convalesce, Novoron Bioscience, Bolden Therapeutics and Myrobalan Therapeutics.

When was Convelo Therapeutics founded?

Convelo Therapeutics was founded in 2016.

Where is Convelo Therapeutics' headquarters located?

Convelo Therapeutics' headquarters is located in Cleveland, OH, US.

When was Convelo Therapeutics' last funding round?

Convelo Therapeutics' most recent funding round was for $10.8M (USD) in December 2022.

How much has Convelo Therapeutics raised to-date?

As of Dec 8, 2022, Convelo Therapeutics has raised a total of $20.6M (USD).

How many employees does Convelo Therapeutics have?

Convelo Therapeutics has 18 employees as of Feb 5, 2024.

Convelo Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medicine
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified